To Evaluate Analgesic Effect of Dexmedetomidine with Ropivacaine in USG Guided Erector Spinae Plane Block for Breast Surgery

To Evaluate Analgesic efficacy of Dexmedetomidine as an adjuvant to Ropivacaine in USG Guided Erector Spinae Plane Block for Modified Radical mastectomy Surgery: A Prospective Randomised, Double blind Clinical study.

Status

Active, not recruiting

Phases

Phase 4

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2020/06/025660

Enrollment

Registered

2020-06-05

Start date

Unknown

Completion date

Unknown

Last updated

2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: C509- Malignant neoplasm of breast of unspecified site

Interventions

Intervention1: Erector Spinae Plane Block: USG guided unilateral Erector spinae Plane Block at T5 level Control Intervention1: Ropivacaine 0.375% 20 ml : Ropivacaine 0.375% 20 ml will be given by USG

Eligibility

Inclusion criteria

Inclusion criteria: ASA Grade I and II Posted for Modified Radical Mastectomy surgery

Exclusion criteria

Exclusion criteria: Patient refusal ASA Grade III and above Drug allergy Obese(BMI >35 kg per sq.m) Bradycardia Coagulopathy Cardiac Conduction Block Infection at Injection site patient n beta blocker or antiplatelet Psychiatric illness Chronic analgesic Use

Design outcomes

Primary

Measure	Time frame
Quality of analgesia Duration of analgesia Timepoint: 24 hour post operatively	—

Secondary

Measure	Time frame
Intra operative hemodynamic Adverse effectTimepoint: Intra operatively 24 hour post operatively	—

Countries

India

Contacts

Public ContactDr Krishna Boliwal

RNT Medical College and Hospital

dr_ikumari@hotmail.com9414176760

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026